Magnesium (Mg)

Overview

Magnesium (Mg) plays an essential role in microbial pathogenesis by influencing bacterial growth, metabolism, and host interactions. As an abundant cation, magnesium is vital for numerous microbial processes such as DNA replication, protein synthesis, and cellular respiration.^[1][2] Pathogens rely on magnesium for the functioning of various enzymes and cellular structures, and its availability can affect microbial virulence.^[3] Magnesium also impacts the host immune response, influencing microbial competition, microbial colonization, and virulence factor expression.^[4][5] Clinically, managing magnesium levels could have therapeutic implications in controlling infections and modulating the microbiome to enhance host defenses.^[6] The metal’s involvement in microbial competition, its role in antimicrobial resistance (AMR), and its ability to affect microbial pathogenesis through direct or indirect mechanisms make it a valuable target for clinical strategies aimed at mitigating infections and improving patient outcomes.^[7]

Chemical Speciation Across Host Niches

It is estimated that half of the magnesium present in the body can be found in bone.^[8] Magnesium speciation across different host niches is influenced by factors such as pH, ionic strength, and the presence of ligands. In body fluids such as saliva, blood, and urine, magnesium primarily exists as free Mg²⁺ ions, but it can also be bound to proteins, like albumin and globulins, or complexed with organic molecules such as citrate and phosphate.^[9] In the gastric lumen, magnesium is largely in its free ionic form due to the acidic pH, which enhances its availability for microbial uptake.^[10] In the small intestine, however, the presence of ligands like phosphate reduces the free Mg²⁺ concentration, thus limiting its bioavailability for pathogens.^[11] In the colon, magnesium exists in higher concentrations and can influence the gut microbiome by promoting the growth of magnesium-requiring pathogens while modulating microbial competition.^[12] These variations in magnesium speciation across different body sites determine the ability of pathogens to acquire magnesium, which is critical for their survival and virulence.^[13] This dynamic interaction between magnesium speciation and microbial systems emphasizes the importance of metal homeostasis in both host defense and microbial pathogenesis.

Microbial Acquisition, Regulation, and Nutritional Toolkit

Magnesium acquisition in pathogens is a highly regulated process that ensures optimal intracellular concentrations necessary for survival and virulence.^[14] Pathogens utilize a variety of mechanisms to acquire magnesium, including high-affinity importers like MgtA and MgtB in Escherichia coli, which are activated under magnesium-limited conditions.^[15] These importers facilitate the uptake of Mg²⁺ from the host environment, where magnesium availability can vary due to host metal-sequestering proteins. In addition to transport systems, pathogens employ metallophores, which are small molecules that chelate magnesium and assist in its uptake from the extracellular environment.^[16] Once inside the cell, magnesium levels are tightly regulated by specific metalloregulatory proteins such as MgtR in Salmonella, which senses intracellular magnesium and modulates gene expression to ensure proper homeostasis.^[17] Additionally, pathogens rely on efflux systems to expel excess magnesium, preventing toxic accumulation.^[18] The interplay between magnesium importers, storage proteins, and efflux systems is essential for microbial survival under various environmental conditions, and it underscores magnesium’s central role in bacterial physiology.

Magnesium Acquisition and Regulation Toolkit

Component Class	Canonical Systems
Importers	MgtA, MgtB, activated under low Mg²⁺ conditions, facilitating Mg uptake).[19]
Metallophores	Mg-specific siderophores in Pseudomonas aeruginosa capture Mg²⁺ from host tissues.[20]
Regulators	MgtR, an Mg²⁺-sensitive regulator in Salmonella that modulates transporter expression.[21]
Efflux	CorB, CorC or CorD.[22]

Metallophores and Community Competition

Magnesium-binding metallophores are secreted by pathogens to capture magnesium from the host and other microbial species. These metallophores are part of the bacterial toolkit for survival and virulence, as they enable bacteria to sequester magnesium when it is in limited supply. Pathogens like Pseudomonas aeruginosa and Streptococcus pneumoniae utilize siderophore-like systems to capture magnesium from host tissues and the surrounding environment.^[23][24] This competition for magnesium can shape microbial community dynamics, especially in polymicrobial infections where multiple species vie for limited resources. Inflammatory responses further influence the production of metallophores, as host immune signals can increase the secretion of magnesium-binding molecules, enhancing the competitive advantage of pathogens that rely on magnesium for growth and virulence. These mechanisms underscore the importance of metal competition in shaping microbial communities and influencing infection outcomes.

Metallophores and Their Ecological Impact

Metallophore or Ligand Complex	Capture System and Ecological Effect
Pseudomonas siderophores	Bind free Mg²⁺, enhancing bacterial competition for magnesium in host tissues.[25]
Streptococcus metallophores	Capture Mg²⁺ from host, increasing virulence and survival in competitive environments.[26]

Virulence Pathway Mapping

Magnesium is integral to the virulence of numerous pathogens, where it activates key enzymes and processes involved in host invasion and immune evasion. In Pseudomonas aeruginosa, the magnesium transporter gene mgtE is essential for inhibiting the type III secretion system (T3SS), which injects bacterial effector proteins into host cells.^[27] By regulating these magnesium-dependent virulence factors, pathogens can establish and maintain infections. Targeting magnesium acquisition pathways, such as the inhibition of magnesium transporters or metallophore systems, offers potential therapeutic strategies to reduce the pathogenicity of these organisms.^[28]

Exposure to Microbiome Outcomes

Magnesium has a profound impact on the microbiome, with variations in its availability influencing microbial diversity and activity. Magnesium influences the growth of both commensal and pathogenic microorganisms, with magnesium-requiring pathogens like Clostridium difficile thriving in magnesium-rich environments.^[29] On the other hand, magnesium deficiency can lead to dysbiosis, characterized by a reduction in beneficial microbes and an overgrowth of pathogenic species.^[30] Magnesium also affects the gut microbiota’s ability to produce metabolites, such as short-chain fatty acids (SCFAs), which are crucial for maintaining intestinal barrier integrity.^[31] Magnesium levels in the gut influence the microbiome’s resistome, the collection of resistance genes that microbes can transfer to each other, potentially promoting antimicrobial resistance (AMR).^[32] The availability of magnesium in the host is thus a key determinant in shaping microbiome dynamics, influencing not only microbial community structure but also host-microbe interactions, immune responses, and infection outcomes.

Exposure Thresholds to Microbiome Selection Signals

Exposure or Concentration Range	Observed or Predicted Microbiome Selection Signal
50-100 μM Mg²⁺	Enhanced growth of C. difficile in gut microbiota, leading to potential dysbiosis.[33]
Low Mg²⁺ (deficiency)	Increased gut permeability and microbial imbalance, potentially leading to chronic diseases.[34]

Antimicrobial Resistance Co-Selection

Magnesium exposure is closely linked to antimicrobial resistance (AMR), as many of the same metal efflux systems involved in magnesium transport also function in the expulsion of antibiotics.^[35] It is not uncommon that when pathogens are exposed to high levels of metals, they may also develop resistance to certain antibiotics due to the cross-regulation of metal and drug resistance pathways.^[36] This phenomenon of co-resistance and co-selection occurs because the genetic pathways that regulate metal ion homeostasis frequently overlap with those involved in antibiotic resistance. Chronic exposure to elevated magnesium levels can therefore lead to the selection of microbial strains resistant to both metals and antibiotics, exacerbating the AMR crisis.^[37] Monitoring magnesium levels and metal efflux activity in clinical settings is crucial for understanding and mitigating the risk of co-selection of AMR in microbial populations.

Assays and Decision Use

Practical assays for measuring magnesium levels in biological specimens include blood, urine, and fecal samples, which can provide valuable insights into the host’s magnesium status and its influence on microbial infections.^[38] Blood magnesium tests help clinicians assess systemic magnesium levels, which can be altered during infection, inflammation, or other disease states for example, acute renal failure.^[39] Urinary magnesium levels, in particular, are useful in diagnosing elevated or decreased magnesium which can be attributed to infections caused by magnesium-dependent pathogens.^[40] These assays provide clinicians with important diagnostic tools for monitoring infection progression and magnesium’s role in modulating microbial behavior.^[41] Furthermore, they can guide the use of magnesium supplementation or chelation therapies as part of a comprehensive treatment strategy for microbial infections.

Biogeography and Body-Site Interactions

Magnesium interacts differently with microbial populations depending on the body site and its associated microenvironment. In the gastrointestinal tract, magnesium plays a key role in regulating microbial growth, particularly influencing magnesium-dependent pathogens that rely on this metal for survival.^[42] Elevated magnesium levels in the gut can promote dysbiosis, especially for pathogens that thrive under magnesium-rich conditions.^[43] In wounds, magnesium is a critical factor in the activation of microbial virulence factors, such as those produced by Staphylococcus aureus, where magnesium availability enhances the production of toxins and the ability to form biofilms.^[44] In systemic infections, magnesium levels can influence bacterial colonization and immune response, either promoting or inhibiting infection depending on the pathogen and the site of infection.^[45][46] Clinicians must therefore monitor magnesium concentrations in various body sites to better understand microbial behavior and inform treatment strategies.

MBTIs and Clinical Strategies

Microbiome-targeted interventions (MBTIs) that modulate magnesium levels can be employed as part of a therapeutic strategy to control microbial infections. One potential strategy is magnesium chelation, which could reduce the virulence of pathogens such as Staphylococcus aureus and Salmonella by limiting magnesium availability.^[47] Conversely, magnesium supplementation might promote the growth of beneficial gut microbiota, improving intestinal barrier function and reducing susceptibility to infection.^[48] These strategies can be combined with other treatments that target microbial metal homeostasis, such as antibiotics or probiotics, to optimize infection control and reduce pathogen colonization.^[49] By targeting the microbial magnesium toolkit, whether through inhibitors of magnesium transporters or the modulation of metallophore production, clinicians can tailor treatments to disrupt pathogen growth and enhance host defense mechanisms.

Intervention to Expected Microbial Effect

Intervention	Expected Microbial or Host-Niche Effect
Magnesium chelation	Reduced microbial virulence in Salmonella.[50] This should be used with caution for patients with magnesium deficiency.
Magnesium supplementation	Magnesium supplementaion leads to enhanced gut barrier function and restoration of microbial diversity.[51]
Combined with antibiotics	Potential synergistic effect on reducing pathogen loadand improving absorption in the gastrointestinal tract.[52]

Knowledge Gaps and Priorities

Despite significant advances in understanding the role of magnesium in microbial pathogenesis, several key uncertainties remain that hinder the clinical application of magnesium-based therapies. The precise mechanisms by which magnesium regulates microbial virulence are still not fully understood, especially in polymicrobial infections. There is a need for more in-depth studies on how magnesium interacts with other metals in the host and how this cross-metal regulation affects pathogen behavior and treatment outcomes.^[53] While magnesium’s role in immune modulation and microbiome dynamics is recognized, the full extent of its influence on microbiome structure, function, and antimicrobial resistance remains unclear.^[54] Specifically, the relationship between magnesium levels and the development of AMR in pathogens requires further investigation.^[55] The impact of magnesium on microbial competition within the microbiome and its potential therapeutic applications in manipulating microbial communities need to be explored more comprehensively. To resolve these knowledge gaps, future research should focus on quantitative studies of magnesium concentrations across different body sites, its effects on microbial enzymatic activity, and the development of assays that measure magnesium’s impact on both host and pathogen. Addressing these gaps will enable the design of targeted therapies that modulate magnesium levels to optimize infection management and microbiome health.

Research Feed

Update History

References

1. Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases.. Fatima, G., Dzupina, A., Alhmadi, H. B., Magomedova, A., Siddiqui, Z., Mehdi, A., & Hadi, N. (2024).. (Cureus, 16(10), e71392.)
2. Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency.. Fiorentini, D.; Cappadone, C.; Farruggia, G.; Prata, C.. (Nutrients 2021, 13, 1136.)
3. Bacterial Mg2+ Homeostasis, Transport, and Virulence.. Groisman, E. A., Hollands, K., Kriner, M. A., Lee, E. J., Park, S. Y., & Pontes, M. H. (2013).. (Annual Review of Genetics, 47, 625.)
4. Understanding How Minerals Contribute to Optimal Immune Function.. Stefanache, A., Lungu, I. I., Butnariu, I. A., Calin, G., Gutu, C., Marcu, C., Grierosu, C., Bogdan Goroftei, E. R., Duceac, L. D., Dabija, M. G., Popa, F., & Damir, D. (2023).. (Journal of Immunology Research, 2023(1), 3355733.)
5. Magnesium Sensing Regulates Intestinal Colonization of Enterohemorrhagic Escherichia coli O157:H7.. Liu, Y., Han, R., Wang, J., Yang, P., Wang, F., & Yang, B. (2020).. (MBio, 11(6), e02470-20.)
6. Understanding How Minerals Contribute to Optimal Immune Function.. Stefanache, A., Lungu, I. I., Butnariu, I. A., Calin, G., Gutu, C., Marcu, C., Grierosu, C., Bogdan Goroftei, E. R., Duceac, L. D., Dabija, M. G., Popa, F., & Damir, D. (2023).. (Journal of Immunology Research, 2023(1), 3355733.)
7. Antimicrobial Properties of Magnesium Open Opportunities to Develop Healthier Food.. Demishtein, K., Reifen, R., & Shemesh, M. (2019).. (Nutrients, 11(10), 2363.)
8. Magnesium: Biochemistry, Nutrition, Detection, and Social Impact of Diseases Linked to Its Deficiency.. Fiorentini, D.; Cappadone, C.; Farruggia, G.; Prata, C.. (Nutrients 2021, 13, 1136.)
9. The Laboratory and Clinical Perspectives of Magnesium Imbalance.. Ab Rahim, S. N., Nordin, N., Azwanee Wan Omar, W. F., Zulkarnain, S., Kumar, S., Sinha, S., & Haque, M. (2023).. (Cureus, 15(12), e49835.)
10. Current opinion on the regulation of small intestinal magnesium absorption.. Chamniansawat, S., Suksridechacin, N., & Thongon, N. (2023).. (World Journal of Gastroenterology, 29(2), 332.)
11. Current opinion on the regulation of small intestinal magnesium absorption.. Chamniansawat, S., Suksridechacin, N., & Thongon, N. (2023).. (World Journal of Gastroenterology, 29(2), 332.)
12. Magnesium Sensing Regulates Intestinal Colonization of Enterohemorrhagic Escherichia coli O157:H7.. Liu, Y., Han, R., Wang, J., Yang, P., Wang, F., & Yang, B. (2020).. (MBio, 11(6), e02470-20.)
13. How pathogens feel and overcome magnesium limitation when in host tissues.. Blanc-Potard, A. B., & Groisman, E. A. (2020).. (Trends in Microbiology, 29(2), 98.)
14. How pathogens feel and overcome magnesium limitation when in host tissues.. Blanc-Potard, A. B., & Groisman, E. A. (2020).. (Trends in Microbiology, 29(2), 98.)
15. The magnesium transporter A is activated by cardiolipin and is highly sensitive to free magnesium in vitro.. Subramani, S., Perdreau-Dahl, H., & Morth, J. P. (2016).. (ELife, 5, e11407.)
16. Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Type III Secretion System Gene Expression by Stimulating rsmYZ Transcription.. Chakravarty, S., Melton, C. N., Bailin, A., Yahr, T. L., & Anderson, G. G. (2017).. (Journal of Bacteriology, 199(23), e00268-17.)
17. The MgtR regulatory peptide negatively controls expression of the MgtA Mg2+ transporter in Salmonella enterica serovar Typhimurium.. Choi, E., Lee, K., & Shin, D. (2012).. (Biochemical and Biophysical Research Communications, 417(1), 318-323.)
18. An Essential Factor for High Mg2+ Tolerance of Staphylococcus aureus.. Armitano, J., Redder, P., Guimarães, V. A., & Linder, P. (2016).. (Frontiers in Microbiology, 7, 227221.)
19. The magnesium transporter A is activated by cardiolipin and is highly sensitive to free magnesium in vitro.. Subramani, S., Perdreau-Dahl, H., & Morth, J. P. (2016).. (ELife, 5, e11407.)
20. Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Type III Secretion System Gene Expression by Stimulating rsmYZ Transcription.. Chakravarty, S., Melton, C. N., Bailin, A., Yahr, T. L., & Anderson, G. G. (2017).. (Journal of Bacteriology, 199(23), e00268-17.)
21. The MgtR regulatory peptide negatively controls expression of the MgtA Mg2+ transporter in Salmonella enterica serovar Typhimurium.. Choi, E., Lee, K., & Shin, D. (2012).. (Biochemical and Biophysical Research Communications, 417(1), 318-323.)
22. An Essential Factor for High Mg2+ Tolerance of Staphylococcus aureus.. Armitano, J., Redder, P., Guimarães, V. A., & Linder, P. (2016).. (Frontiers in Microbiology, 7, 227221.)
23. Widespread fungal–bacterial competition for magnesium lowers bacterial susceptibility to polymyxin antibiotics.. Hsieh Y-YP, Sun W, Young JM, Cheung R, Hogan DA, Dandekar AA, et al. (2024). (PLoS Biol 22(6): e3002694.)
24. Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention.. K Brooks, L. R., & Mias, G. I. (2018).. (Frontiers in Immunology, 9, 1366.)
25. Widespread fungal–bacterial competition for magnesium lowers bacterial susceptibility to polymyxin antibiotics.. Hsieh Y-YP, Sun W, Young JM, Cheung R, Hogan DA, Dandekar AA, et al. (2024). (PLoS Biol 22(6): e3002694.)
26. Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention.. K Brooks, L. R., & Mias, G. I. (2018).. (Frontiers in Immunology, 9, 1366.)
27. Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Type III Secretion System Gene Expression by Stimulating rsmYZ Transcription.. Chakravarty, S., Melton, C. N., Bailin, A., Yahr, T. L., & Anderson, G. G. (2017).. (Journal of Bacteriology, 199(23), e00268-17.)
28. Pseudomonas aeruginosa Magnesium Transporter MgtE Inhibits Type III Secretion System Gene Expression by Stimulating rsmYZ Transcription.. Chakravarty, S., Melton, C. N., Bailin, A., Yahr, T. L., & Anderson, G. G. (2017).. (Journal of Bacteriology, 199(23), e00268-17.)
29. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions.. Kochan TJ, Shoshiev MS, Hastie JL, Somers MJ, Plotnick YM, Gutierrez-Munoz DF, Foss ED, Schubert AM, Smith AD, Zimmerman SK, Carlson PE, Hanna PC.2018.. (mSphere3:10.1128/msphere.00335-18.)
30. Effect of Dietary Magnesium Content on Intestinal Microbiota of Rats.. García-Legorreta, A., Soriano-Pérez, L. A., Flores-Buendía, A. M., Medina-Campos, O. N., Noriega, L. G., Granados-Portillo, O., Nambo-Venegas, R., Tovar, A. R., Mendoza-Vargas, A., Barrera-Oviedo, D., Pedraza-Chaverri, J., & Palacios-González, B. (2020).. (Nutrients, 12(9), 2889.)
31. Combined resistant dextrin and low-dose Mg oxide administration increases short-chain fatty acid and lactic acid production by gut microbiota.. Sasaki, H., Hayashi, K., Imamura, M., Hirota, Y., Hosoki, H., Nitta, L., Furutani, A., & Shibata, S. (2023).. (The Journal of Nutritional Biochemistry, 120, 109420.)
32. Magnesium modulates phospholipid metabolism to promote bacterial phenotypic resistance to antibiotics.. Li, H., Yang, J., Kuang, S. F., Fu, H. Z., Lin, H. Y., & Peng, B. (2025).. (ELife, 13, RP100427.)
33. Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions.. Kochan TJ, Shoshiev MS, Hastie JL, Somers MJ, Plotnick YM, Gutierrez-Munoz DF, Foss ED, Schubert AM, Smith AD, Zimmerman SK, Carlson PE, Hanna PC.2018.. (mSphere3:10.1128/msphere.00335-18.)
34. Magnesium Matters: A Comprehensive Review of Its Vital Role in Health and Diseases.. Fatima, G., Dzupina, A., Alhmadi, H. B., Magomedova, A., Siddiqui, Z., Mehdi, A., & Hadi, N. (2024).. (Cureus, 16(10), e71392.)
35. Magnesium modulates phospholipid metabolism to promote bacterial phenotypic resistance to antibiotics.. Li, H., Yang, J., Kuang, S. F., Fu, H. Z., Lin, H. Y., & Peng, B. (2025).. (ELife, 13, RP100427.)
36. Metal‐regulated antibiotic resistance and its implications for antibiotic therapy.. Xu, Z., & Lin, X. (2024).. (Microbial Biotechnology, 17(7), e14537.)
37. Magnesium modulates phospholipid metabolism to promote bacterial phenotypic resistance to antibiotics.. Li, H., Yang, J., Kuang, S. F., Fu, H. Z., Lin, H. Y., & Peng, B. (2025).. (ELife, 13, RP100427.)
38. Measuring magnesium – Physiological, clinical and analytical perspectives.. Dent, A., & Selvaratnam, R. (2022).. (Clinical Biochemistry, 105-106, 1-15.)
39. Measuring magnesium – Physiological, clinical and analytical perspectives.. Dent, A., & Selvaratnam, R. (2022).. (Clinical Biochemistry, 105-106, 1-15.)
40. Measuring magnesium – Physiological, clinical and analytical perspectives.. Dent, A., & Selvaratnam, R. (2022).. (Clinical Biochemistry, 105-106, 1-15.)
41. Magnesium: The overlooked electrolyte in blood cancers?. Gile, J., Ruan, G., Abeykoon, J., McMahon, M. M., & Witzig, T. (2020).. (Blood Reviews, 44, 100676.)
42. Magnesium treatment increases gut microbiome synthesizing vitamin D and inhibiting colorectal cancer: Results from a double-blind precision-based randomized placebo-controlled trial.. Sun, E., Zhu, X., Ness, R. M., Murff, H. J., Sun, S., Yu, C., Fan, L., Azcarate-Peril, M. A., Shrubsole, M. J., & Dai, Q. (2025).. (The American Journal of Clinical Nutrition, 122(5), 1185.)
43. Magnesium Orotate and the Microbiome–Gut–Brain Axis Modulation: New Approaches in Psychological Comorbidities of Gastrointestinal Functional Disorders.. Schiopu, C., Ștefănescu, G., Diaconescu, S., Bălan, G. G., Gimiga, N., Rusu, E., Moldovan, C. A., Popa, B., Tataranu, E., Olteanu, A. V., Boloș, A., & Ștefănescu, C.. (Nutrients. 2022; 14(8):1567.)
44. Antimicrobial Properties of Magnesium Open Opportunities to Develop Healthier Food.. Demishtein, K., Reifen, R., & Shemesh, M. (2019).. (Nutrients, 11(10), 2363.)
45. Understanding How Minerals Contribute to Optimal Immune Function.. Stefanache, A., Lungu, I. I., Butnariu, I. A., Calin, G., Gutu, C., Marcu, C., Grierosu, C., Bogdan Goroftei, E. R., Duceac, L. D., Dabija, M. G., Popa, F., & Damir, D. (2023).. (Journal of Immunology Research, 2023(1), 3355733.)
46. A narrative review on the role of magnesium in immune regulation, inflammation, infectious diseases, and cancer.. Ashique, S., Kumar, S., Hussain, A., Mishra, N., Garg, A., Jaswanth Gowda, B. H., Farid, A., Gupta, G., Dua, K., & Taghizadeh-Hesary, F. (2023).. (Journal of Health, Population, and Nutrition, 42, 74.)
47. How pathogens feel and overcome magnesium limitation when in host tissues.. Blanc-Potard, A. B., & Groisman, E. A. (2020).. (Trends in Microbiology, 29(2), 98.)
48. Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota.. Chierico, F. D., Trapani, V., Petito, V., Reddel, S., Pietropaolo, G., Graziani, C., Masi, L., Gasbarrini, A., Putignani, L., Scaldaferri, F., & Wolf, F. I. (2021).. (Nutrients, 13(12), 4188.)
49. Optimizing Magnesium Uptake in Lacticaseibacillus Rhamnosus To Advance Nutribiotic Strategies.. Varvara, R. A., Budde, H., Ley, R., & Vodnar, D. C. (2026).. (Current Microbiology, 83(2), 132.)
50. How pathogens feel and overcome magnesium limitation when in host tissues.. Blanc-Potard, A. B., & Groisman, E. A. (2020).. (Trends in Microbiology, 29(2), 98.)
51. Dietary Magnesium Alleviates Experimental Murine Colitis through Modulation of Gut Microbiota.. Chierico, F. D., Trapani, V., Petito, V., Reddel, S., Pietropaolo, G., Graziani, C., Masi, L., Gasbarrini, A., Putignani, L., Scaldaferri, F., & Wolf, F. I. (2021).. (Nutrients, 13(12), 4188.)
52. Optimizing Magnesium Uptake in Lacticaseibacillus Rhamnosus To Advance Nutribiotic Strategies.. Varvara, R. A., Budde, H., Ley, R., & Vodnar, D. C. (2026).. (Current Microbiology, 83(2), 132.)
53. How pathogens feel and overcome magnesium limitation when in host tissues.. Blanc-Potard, A. B., & Groisman, E. A. (2020).. (Trends in Microbiology, 29(2), 98.)
54. The essential role of magnesium in immunity and gut health: Impacts of dietary magnesium restriction on peritoneal cells and intestinal microbiome.. Lima, F. D. S., Santos, M. Q. D., Makiyama, E. N., Hoffmann, C., & Fock, R. A. (2025).. (Journal of Trace Elements in Medicine and Biology, 88, 127604.)
55. Magnesium modulates phospholipid metabolism to promote bacterial phenotypic resistance to antibiotics.. Li, H., Yang, J., Kuang, S. F., Fu, H. Z., Lin, H. Y., & Peng, B. (2025).. (ELife, 13, RP100427.)